Meyeon Park, MD, MAS

Associate Professor

My research focuses on patient outcomes in genetic kidney diseases including polycystic kidney disease and APOL1-mediated kidney disease. I am the medical director of the UCSF PKD Center of Excellence and principal investigator of the UCSF Cardiovascular Risk After Kidney Transplantation (CARAKTER) study.

EDUCATION
College: Harvard College
Medical School: University of Pennsylvania School of Medicine
Other Graduate Training: University of California, San Francisco, MAS
Internal Medicine Residency: Yale-New Haven Hospital
Nephrology Fellowship: University of California, San Francisco

Education
2019 - Diversity, Equity, and Inclusion Champion Training, University of California
2013 - Nephrology fellowship, University of California, San Francisco
M.A.S. in Clinical Research, 2012 - Graduate Division (Advanced Training in Clinical Research), University of California, San Francisco
2009 - Internal Medicine Residency, Yale-New Haven Hospital
M.D., 2006 - School of Medicine, University of Pennsylvania
Honors and Awards
  • Physician Gratitude Award, National PKD Foundation, 2017
  • Clinical Scientist Development Award, Doris Duke Charitable Foundation, 2015-2018
  • Pilot for Junior Investigators in Basic and Clinical/Translational Sciences, UCSF CTSI, 2015-2016
  • Centers of Excellence in Patient Research Pilot Award, UCSF Department of Medicine, 2014-2015
  • K23 Career Development Award, NIH NIDDK, 2013-2018
Publications

  1. Diana Etwaru, Ying Gao, Meyeon Park. Patient Experience with Genetic Testing in ADPKD. Journal of the American Society of Nephrology 2024. PMID:


  2. Liu X, Lai YC, Cui D, Kung SC, Park M, Zoltan L, Larson PEZ, Wang ZJ. Initial Experience of Metabolic Imaging with Hyperpolarized [1-13C]pyruvate MRI in Kidney Transplant Patients. ArXiv 2024. PMID: 39314508


  3. Liu X, Lai YC, Cui D, Kung SC, Park M, Laszik Z, Larson PEZ, Wang ZJ. Initial Experience of Metabolic Imaging With Hyperpolarized [1-13C]pyruvate MRI in Kidney Transplant Patients. Journal of magnetic resonance imaging : JMRI 2024. PMID: 39239784


  4. Hoover E, Holliday V, Merullo N, Oberdhan D, Perrone RD, Rusconi C, Park M, Phadnis MA, Thewarapperuma N, Dahl NK. Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry. Kidney Medicine 2024. PMID: 38689835


  5. Eswarappa M, Park M. All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: PRO. Kidney360 2023. PMID: 37990366


  6. Allen Chao, Ying Gao, Diana Etwaru, Meyeon Park. ADPKD Comorbid Conditions at a PKD-Focused Center. Complement Activation 2023. PMID:


  7. Wais T, Ibarra KP, Sudarshana DM, Eswarappa M, Park M, Gallagher RC, Tsui B, Teixeira S, Josephson SA, Richie M. 41-Year-Old Male with Sub-Acute Encephalopathy, Seizures, and End Stage Renal Disease: A Unifying Diagnosis and Response to Therapy. The Neurohospitalist 2023. PMID: 38235033


  8. Smith J, Harris OO, Adey D, Park M. Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach. BMC nephrology 2023. PMID: 37127564


  9. Ackley W, Dahl NK, Park M. Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease. Advances in kidney disease and health 2023. PMID: 37088525


  10. Jose M Rodriguez Valadez, Malak Tahsin, Umesh Masharani, Meyeon Park, M.G. Myriam Hunink, Joseph Yeboah, Lihua Li, Ellerie Weber, Yan Li, Asem Berkalieva, Luuk Avezaat, Wendy Max, Kirsten E Fleischmann, Bart S Ferket. Abstract P140: Potential Mediators for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis. Circulation 2023. PMID:


  11. Lai M, Aras MA, Park M. Post-transplant ejection fraction and renal failure in cardiac transplant recipients: An analysis of the OPTN database. Clinical transplantation 2022. PMID: 36504467


  12. Postalcioglu M, Cullaro G, Park M. Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD. American journal of kidney diseases : the official journal of the National Kidney Foundation 2022. PMID: 36528464


  13. Allen Chao, Ying Gao, Jordan Jiang, Diana Etwaru, Adesuwa N. Osunde, Laalasa Varanasi, Stephen L. Gluck, Gabriel Loeb, Meyeon Park. Experience With Genetic Testing at a Large Polycystic Kidney Disease-Focused Program. Complement Activation 2022. PMID:


  14. Allen Chao, Ying Gao, Jordan Jiang, Adesuwa N. Osunde, Diana Etwaru, Laalasa Varanasi, Stephen L. Gluck, Meyeon Park. Tolvaptan Use at a Large PKD-Focused Program. Complement Activation 2022. PMID:


  15. JOSE M. RODRIGUEZ-VALADEZ, MYRIAM HUNINK, UMESH MASHARANI, JOSEPH YEBOAH, MEYEON PARK, LIHUA LI, ELLERIE WEBER, YAN LI, ASEM BERKALIEVA, WENDY MAX, KIRSTEN FLEISCHMANN, BART FERKET. 871-P: Weight Change as Mediator for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis. Diabetes 2022. PMID:


  16. JOSE M. RODRIGUEZ-VALADEZ, MYRIAM HUNINK, UMESH MASHARANI, JOSEPH YEBOAH, MEYEON PARK, LIHUA LI, ELLERIE WEBER, YAN LI, ASEM BERKALIEVA, WENDY MAX, KIRSTEN FLEISCHMANN, BART FERKET. 872-P: Cardiovascular Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Meta-Regression Analysis of 17 Randomized Trials. Diabetes 2022. PMID:


  17. Hoover E, Perrone RD, Rusconi C, Benson B, Dahl NK, Gitomer B, Manelli A, Mrug M, Park M, Seliger SL, Phadnis MA, Thewarapperuma N, Watnick TJ. Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Kidney360 2022. PMID: 36176661


  18. Lai M, Gao Y, Tavakol M, Freise C, Lee BK, Park M. Pretransplant Dialysis and Preemptive Transplant in Living Donor Kidney Recipients. Kidney360 2022. PMID: 35845334


  19. Lassen MCH, Qasim A, Webber A, Gao Y, Biering-Sørensen T, Park M. The effect of kidney transplantation on left ventricular remodeling and global diastolic strain rate in end-stage renal disease. 2021. PMID: 34713484


  20. Elise Hoover, Beverly A. Benson, Neera K. Dahl, Berenice Y. Gitomer, Amy Manelli, Michal Mrug, Meyeon Park, Chris Rusconi, Stephen L. Seliger, Ronald D. Perrone, Terry J. Watnick. Two Years In: The Development and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Complement Activation 2021. PMID:


  21. Birdwell KA, Park M. Post-Transplant Cardiovascular Disease. Clinical journal of the American Society of Nephrology : CJASN 2021. PMID: 34556500


  22. Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P. Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients. Journal of the National Comprehensive Cancer Network : JNCCN 2020. PMID: 33152701


  23. Elise Hoover, David Baron, Beverly A. Benson, Berenice Y. Gitomer, Klee R. Kleber, Amy Manelli, Michal Mrug, Meyeon Park, Chris Rusconi, Stephen L. Seliger, Ronald D. Perrone, Terry J. Watnick. Design and Basic Characteristics of a National Patient Registry in ADPKD. Complement Activation 2020. PMID:


  24. Vest LS, Sarabu N, Koraishy FM, Nguyen MT, Park M, Lam NN, Schnitzler MA, Axelrod D, Hsu CY, Garg AX, Segev DL, Massie AB, Hess GP, Kasiske BL, Lentine KL. Prescription Patterns of Opioids and Non-Steroidal Anti-Inflammatory Drugs in the First Year After Living Kidney Donation: An Analysis of U.S. Registry and Pharmacy Fill Records. Clinical transplantation 2020. PMID: 32502285


  25. Freise J, Cadwell C, Park M, Freise C. Development of renal cysts in a transplanted kidney. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020. PMID: 32472640


  26. Chloe Evelyn Atreya, Meyeon Park, James P. Grenert, Spencer Behr, Amalia Gonzalez, Jonathan Chou, Samantha Maisel, Terence W. Friedlander, Chris E. Freise, Jun Shoji, Thomas John Semrad, Peter Chin-Hong, Eric A. Collisson, Jessica Van Ziffle. Molecular characterization of a gastric cancer transmitted from an organ donor to four transplant recipients. Journal of Clinical Oncology 2020. PMID:


  27. Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney international reports 2019. PMID: 32154449


  28. Lassen MCH, Qasim AN, Biering-Sørensen T, Reeh JLT, Watnick T, Seliger SL, Chen H, Sawan MA, Nguyen D, Li Y, Hong SN, Park M. Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients. BMC nephrology 2019. PMID: 31419965


  29. Norton JM, Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P. Development and Validation of a Pragmatic Electronic Phenotype for CKD. Clinical journal of the American Society of Nephrology : CJASN 2019. PMID: 31405830


  30. Lentine KL, Holscher CM, Naik AS, Lam NN, Segev DL, Garg AX, Axelrod D, Xiao H, Henderson ML, Massie AB, Kasiske BL, Hess GP, Hsu CY, Park M, Schnitzler MA. Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation. Transplantation direct 2019. PMID: 31576370


  31. Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M. Primary aldosteronism associated with a germline variant in CACNA1H. BMJ case reports 2019. PMID: 31126930


  32. Freise J, Tavakol M, Gao Y, Klein O, Lee BK, Freise C, Park M. The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD. Kidney international reports 2019. PMID: 30993236


  33. Chirumamilla R, Mina D, Siyahian S, Park M. Subclinical metabolic and cardiovascular abnormalities in autosomal dominant polycystic kidney disease?. Clinical nephrology 2018. PMID: 30106364


  34. Weiner DE, Park M, Tighiouart H, Joseph AA, Carpenter MA, Goyal N, House AA, Hsu CY, Ix JH, Jacques PF, Kew CE, Kim SJ, Kusek JW, Pesavento TE, Pfeffer MA, Smith SR, Weir MR, Levey AS, Bostom AG. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 2018. PMID: 30037726


  35. Cullaro G, Park M, Lai JC. "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis. Hepatology (Baltimore, Md.) 2018. PMID: 29698588


  36. Park M, Nussbaum RL. Recurrent Renal Cysts in a Transplanted Kidney. Annals of internal medicine 2018. PMID: 29971405


  37. Park M, Maristany D, Huang D, Shlipak MG, Whooley M. Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul Study. Data in brief 2017. PMID: 28831402


  38. Tran WC, Huynh D, Chan T, Chesla CA, Park M. Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease. BMC nephrology 2017. PMID: 28679364


  39. Park M, Maristany D, Huang D, Shlipak MG, Whooley M. Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study. Atherosclerosis 2017. PMID: 28601698


  40. Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clinical journal of the American Society of Nephrology : CJASN 2017. PMID: 28254771


  41. Park M, Shlipak MG, Thiessen-Philbrook H, Garg AX, Koyner JL, Coca SG, Parikh CR. Association of Peak Changes in Plasma Cystatin C and Creatinine With Death After Cardiac Operations. The Annals of thoracic surgery 2016. PMID: 26921980


  42. Park M, Shlipak MG, Vittinghoff E, Katz R, Siscovick D, Sarnak M, Lima JA, Hsu CY, Peralta CA. Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Clinical nephrology 2015. PMID: 26558369


  43. Bansal N, Carpenter MA, Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J, Hunsicker LG, Park M, Bennett M, Liu KD, Hsu CY. Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial. Journal of the American Society of Nephrology : JASN 2015. PMID: 26538631


  44. Park M, Kulkarni A, Beatty A, Ganz P, Regan M, Vittinghoff E, Whooley M. Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study. Atherosclerosis 2015. PMID: 26523992


  45. Wu EH, Wojciechowski D, Chandran S, Yeh BM, Park M, Westphalen A, Wang ZJ. Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology. Transplant international : official journal of the European Society for Organ Transplantation 2015. PMID: 26011061


  46. Park M. Islands in the stream: the risk of kidney disease from cardiovascular disease. American journal of kidney diseases : the official journal of the National Kidney Foundation 2015. PMID: 25919498


  47. Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clinical journal of the American Society of Nephrology : CJASN 2015. PMID: 25605700


  48. Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM. Relationship between kidney disease and endothelial function in peripheral artery disease. Journal of vascular surgery 2014. PMID: 25441679


  49. Park M, Vittinghoff E, Shlipak MG, Mishra R, Whooley M, Bansal N. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study. American heart journal 2014. PMID: 25458658


  50. Karen C Chong, Christopher D Owens, Meyeon Park, Hugh F Alley, Michael S Conte, Warren J Gasper, Marlene Grenon. Abstract 314: Determinants of Endothelial Dysfunction in Peripheral Artery Disease: Importance of Kidney Disease. Arteriosclerosis Thrombosis and Vascular Biology 2014. PMID:


  51. Park M, Hsu CY. An ACE in the hole for patients with advanced chronic kidney disease? JAMA internal medicine 2014. PMID: 24342932


  52. Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD. Urine stability studies for novel biomarkers of acute kidney injury. American journal of kidney diseases : the official journal of the National Kidney Foundation 2013. PMID: 24200462


  53. Park M, Vittinghoff E, Ganz P, Peralta CA, Whooley M, Shlipak MG. Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study. Arteriosclerosis, thrombosis, and vascular biology 2013. PMID: 24177327


  54. Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY. Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation. Biomarker insights 2013. PMID: 23531625


  55. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG. Associations between kidney function and subclinical cardiac abnormalities in CKD. Journal of the American Society of Nephrology : JASN 2012. PMID: 22935481


  56. Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clinical journal of the American Society of Nephrology : CJASN 2012. PMID: 22580783


  57. Park M, Coca SG, Nigwekar SU, Garg AX, Garwood S, Parikh CR. Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review. American journal of nephrology 2010. PMID: 20375494


  58. Park M, Hryniewicz K, Setaro JF. Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hemorrhage, and cyclic hypotension: case report and review of unusual presentations of pheochromocytoma. Journal of clinical hypertension (Greenwich, Conn.) 2009. PMID: 19222671


  59. Park M, Davidson R, Fox K. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer. Seminars in oncology 2006. PMID: 17145346